SEEK

For profitWebsite ↗

Also known as: PepTcell Limited | SEEK

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Nov 1, 2009

Last known activity

Jul 8, 2019

Timeline

2000s

Jan 1, 2004
SEEK— Founded

Drugs by trial phase (7 distinct, 6 trials)

Phase 2 (2 own, 0 via acquisition)

fluarix
adjuvanted flu-v

Phase 1 (5 own, 0 via acquisition)

aluminum hydroxide
ags-v
polypeptide t-cell epitope sequences
inactivated influenza vaccine
isa-51

Indications

Studied for

Communicable Diseases
HIV Infections
Infections
Influenza, Human

Recent trials (8)

NCT04009824CollaboratorPhase 1Jul 8, 2019
NCT03180801Lead sponsorPhase 2Aug 18, 2016
NCT02962908Lead sponsorPhase 2Aug 1, 2016
NCT01226758Lead sponsorPhase 1Jun 1, 2010
NCT01181336Lead sponsorPhase 1Apr 1, 2010
NCT01181336Study directorPhase 1Apr 1, 2010
NCT01071031Study directorPhase 1Nov 1, 2009
NCT01071031Lead sponsorPhase 1Nov 1, 2009

Details

Founded: London, GB Jan 1, 2004
Last known activity: Jul 8, 2019

Notes

--- Pre-folding founded info: 2010-01-01 London GB https://www.prnewswire.com/news-releases/seek-peptcell-changes-name-due-to-new-focus-and-success-111105494.html ---